Rationale for Combing Stereotactic Body Radiation Therapy with Immune Checkpoint Inhibitors in Medically Inoperable Early-Stage Non-Small Cell Lung Cancer

Rationale for Combing Stereotactic Body Radiation Therapy with Immune Checkpoint Inhibitors in Medically Inoperable Early-Stage Non-Small Cell Lung Cancer

Stereotactic body radiation therapy (SBRT) has been widely adopted as an alternative to lobar resection in medically inoperable patients with lymph-node negative (N0) early-stage (ES) non-small cell lung cancer (NSCLC). Excellent in-field local control has been consistently achieved with SBRT in ES...

Full description

Bibliographic Details
Main Authors: Alexander Chi, Nam P. Nguyen
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
early-stage NSCLC
stereotactic body radiation therapy
SBRT
immune checkpoint inhibitors
Online Access:https://www.mdpi.com/2072-6694/14/13/3144

Similar Items

Similar Items